HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chronic kidney disease and diabetes mellitus predict resistance to vitamin D replacement therapy.

AbstractBACKGROUND:
25-Hydroxyvitamin D [25(OH)D] is a marker of nutritional status; however, chronic kidney disease (CKD) results in alterations in vitamin D metabolism, including the loss of vitamin D-binding proteins and alterations in CYP27B1 and CYP24 enzymes that metabolize 25(OH)D. This study was designed to determine the predictors of responsiveness to correction of vitamin D deficiency with oral vitamin D2 (ergocalciferol) in adults.
METHODS:
A retrospective study of 183 veterans with 25(OH)D level <30 ng/mL, who were treated with 50,000 IU per week of vitamin D2, was performed. Logistic regression models were developed to determine the factors predicting the response to treatment, defined as either the change in serum 25(OH)D level/1000 IU of vitamin D2 or the number of vitamin D2 doses (50,000 IU per dose) administered.
RESULTS:
The mean age of the patients was 63 ± 12 years. About 87% were men and 51% diabetic, and 29% had an estimated glomerular filtration rate of <60 mL/min/1.73 m. The average number of vitamin D2 doses was 10.91 ± 5.95; the average increase in 25(OH)D level was 18 ± 10.80 ng/mL. 25(OH)D levels remained <30 ng/mL in 61 patients after treatment. A low estimated glomerular filtration rate and the presence of diabetes mellitus were significant independent predictors for inadequate response to vitamin D2 treatment in logistic regression models. Patients with CKD required greater amounts of vitamin D2 to achieve similar increases in 25(OH)D levels, versus non-CKD patients.
CONCLUSIONS:
The presence of CKD and diabetes mellitus is associated with resistance to correction of 25(OH)D deficiency with vitamin D2 therapy. The underlying mechanism needs to be evaluated in prospective studies.
AuthorsHala M Alshayeb, Barry M Wall, Arif Showkat, L Darryl Quarles, Therese Mangold
JournalThe American journal of the medical sciences (Am J Med Sci) Vol. 345 Issue 4 Pg. 314-320 (Apr 2013) ISSN: 1538-2990 [Electronic] United States
PMID23221508 (Publication Type: Journal Article)
Chemical References
  • Ergocalciferols
  • Vitamins
Topics
  • Aged
  • Diabetes Complications (complications, drug therapy)
  • Drug Resistance
  • Ergocalciferols (therapeutic use)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Renal Insufficiency, Chronic (complications)
  • Retrospective Studies
  • Vitamin D Deficiency (drug therapy)
  • Vitamins (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: